Cargando…
The impact of adjuvant therapy in patients with biochemical recurrence on prostate cancer progression and mortality five years after radical prostatectomy
INTRODUCTION: The clinical significance of biochemical recurrence (BCR) after radical prostatectomy (RP) due to prostate cancer (PCa) is not unambiguous, sometimes being independent from the real progression. BCR is followed by a greater risk of adverse events and almost always results with the nece...
Autores principales: | Fryczkowski, Mieczysław, Bryniarski, Piotr, Szczębara, Maciej, Suchodolski, Marian, Paradysz, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921737/ https://www.ncbi.nlm.nih.gov/pubmed/24578897 http://dx.doi.org/10.5173/ceju.2011.04.art6 |
Ejemplares similares
-
PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011) -
Are Diabetic Patients at Increased Risk for Biochemical Recurrence After Radical Prostatectomy?
por: Ben Hadj Alouane, Houssem, et al.
Publicado: (2022) -
Prognostic value of radical cystoprostatectomy in men with bladder cancer infiltrating prostate versus co-existing prostate cancer: a research study
por: Bryniarski, Piotr, et al.
Publicado: (2010) -
Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
por: Ahlberg, Mats Steinholtz, et al.
Publicado: (2022) -
Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy
por: Morka, Naomi, et al.
Publicado: (2021)